日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Sporadic medullary thyroid carcinoma with a rare RET transmembrane domain mutation (A641R) that responds to selpercatinib

散发性甲状腺髓样癌伴有罕见的RET跨膜结构域突变（A641R），对selpercatinib有反应

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyaf209
Fukuda, Naoki; Toda, Kazuhisa; Chiba, Tomohiro; Fukada, Ippei; Mori, Seiichi; Tonooka, Akiko; Toda, Erisa; Yoshida, Jumpei; Wang, Xiaofei; Oki, Ryosuke; Nakao, Takehiro; Urasaki, Tetsuya; Nakano, Kenji; Ono, Makiko; Tomomatsu, Junichi; Takeuchi, Kengo; Takahashi, Shunji; Miura, Yuji
肿瘤
肿瘤免疫
RET
免疫/内分泌
发表日期：2025
文献求助 收藏

PARP inhibitors elicit a cellular senescence mediated inflammatory response in homologous recombination proficient cancer cells.

PARP抑制剂可引起同源重组能力强的癌细胞发生细胞衰老介导的炎症反应

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-00336-4
Kamii Misato, Kamata Ryo, Saito Hitoshi, Yamamoto Gaku, Mashima Chiaki, Yamauchi Toyohiro, Nakao Takehiro, Sakae Yuta, Yamamori-Morita Tomoko, Nakai Kazuki, Hakozaki Yumi, Takenaka Masataka, Okamoto Aikou, Ohashi Akihiro
细胞生物学
Senescence
炎症
细胞衰老
发表日期：2025
文献求助 收藏

The Impact of Carboplatin Dosing Design Using Adjusted Serum Creatinine on Carboplatin Plus Paclitaxel Therapy for Ovarian Cancer

调整血清肌酐水平后卡铂给药方案对卵巢癌卡铂联合紫杉醇治疗的影响

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.70804
Kato, Shu; Baba, Kaede; Mamishin, Kanako; Uematsu, Mao; Shimura, Mai; Hirota, Akira; Fukuda, Misao; Takahashi, Nobuyuki; Nakao, Takehiro; Nakajima, Hiromichi; Funasaka, Chikako; Kondoh, Chihiro; Harano, Kenichi; Naito, Yoichi; Matsubara, Nobuaki; Hosono, Ako; Kawasaki, Toshikatsu; Mukohara, Toru
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Confirmatory diagnosis and successive chemotherapeutic treatments of metastatic skeletal EWSR1::NFATC2 sarcoma: A case report

转移性骨骼EWSR1::NFATC2肉瘤的确诊及后续化疗：病例报告

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2024.14854
Urasaki, Tetsuya; Ono, Makiko; Yamashita, Kyoko; Tanizawa, Taisuke; Togashi, Yuki; Ohmoto, Akihiro; Suto, Hirotaka; Oki, Ryosuke; Wang, Xiaofei; Nakao, Takehiro; Sato, Yasuyoshi; Fukuda, Naoki; Nakano, Kenji; Tomomatsu, Junichi; Saito, Masanori; Hayakawa, Keiko; Takeuchi, Kengo; Matsumoto, Seiichi; Ae, Keisuke; Takahashi, Shunji
EWS
发表日期：2025
文献求助 收藏

The first case of GOLGA5-RET fusion-positive malignant spindle cell sarcoma of the head and neck responsive to selpercatinib

首例对selpercatinib有反应的GOLGA5-RET融合阳性头颈部恶性梭形细胞肉瘤病例

期刊:International Cancer Conference Journal
影响因子:0.5
doi:10.1007/s13691-025-00806-6
Nakao, Takehiro; Fukuda, Naoki; Wang, Xiaofei; Oki, Ryosuke; Urasaki, Tetsuya; Nakano, Kenji; Ono, Makiko; Tomomatsu, Junichi; Ariyasu, Ryo; Sato, Yukiko; Fukada, Ippei; Sasaki, Toru; Takeuchi, Kengo; Nishio, Makoto; Miura, Yuji; Takahashi, Shunji
细胞生物学
RET
发表日期：2025
文献求助 收藏

Pathophysiological Implications of Protein Lactylation in Pancreatic Epithelial Tumors

蛋白质乳酸化在胰腺上皮肿瘤中的病理生理意义

期刊:Acta Histochemica et Cytochemica
影响因子:1.6
doi:10.1267/ahc.24-00010
Tomoki Takata, Akihiro Nakamura, Hiroaki Yasuda, Hayato Miyake, Yoshio Sogame, Yuki Sawai, Michiyo Hayakawa, Kentaro Mochizuki, Ryuta Nakao, Takehiro Ogata, Hisashi Ikoma, Eiichi Konishi, Yoshinori Harada, Eigo Otsuji, Yoshito Itoh, Hideo Tanaka
肿瘤
胰腺癌
FCM
IF
WB
发表日期：2024
文献求助 收藏

Efficacy of a platinum-based chemotherapy rechallenge for platinum-sensitive recurrence after PARP inhibitor maintenance

PARP抑制剂维持治疗后，铂类化疗再次挑战对铂敏感复发的疗效

期刊:Gynecologic Oncology Reports
影响因子:1.3
doi:10.1016/j.gore.2024.101482
Nakao, Takehiro; Harano, Kenichi; Wakabayashi, Masashi; Naito, Yoichi; Tanabe, Hiroshi; Mukohara, Toru
PARP
发表日期：2024
文献求助 收藏

The impact of the COVID-19 pandemic on perioperative chemotherapy for breast cancer

新冠疫情对乳腺癌围手术期化疗的影响

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.5898
Baba, Kaede; Kawamoto, Megumi; Mamishin, Kanako; Uematsu, Mao; Kiyohara, Hikari; Hirota, Akira; Takahashi, Nobuyuki; Fukuda, Misao; Kusuhara, Shota; Nakajima, Hiromichi; Funasaka, Chikako; Nakao, Takehiro; Kondoh, Chihiro; Harano, Kenichi; Matsubara, Nobuaki; Naito, Yoichi; Hosono, Ako; Kawasaki, Toshikatsu; Mukohara, Toru
新冠
肿瘤
肿瘤免疫
乳腺癌
微生物学
发表日期：2023
文献求助 收藏

Impacts of clinicopathological factors on efficacy of trastuzumab deruxtecan in patients with HER2-positive metastatic breast cancer

临床病理因素对曲妥珠单抗德鲁替康治疗HER2阳性转移性乳腺癌患者疗效的影响

期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2022.01.002
Nakajima, Hiromichi; Harano, Kenichi; Nakai, Tokiko; Kusuhara, Shota; Nakao, Takehiro; Funasaka, Chikako; Kondoh, Chihiro; Matsubara, Nobuaki; Naito, Yoichi; Hosono, Ako; Mitsunaga, Shuichi; Ishii, Genichiro; Mukohara, Toru
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis

紫杉醇联合贝伐单抗治疗伴有内脏危象的乳腺癌患者的疗效和安全性

期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2021.04.001
Funasaka, Chikako; Naito, Yoichi; Kusuhara, Shota; Nakao, Takehiro; Fukasawa, Yoko; Mamishin, Kanako; Komuro, Ayumi; Okunaka, Mashiro; Kondoh, Chihiro; Harano, Kenichi; Kogawa, Takahiro; Matsubara, Nobuaki; Hosono, Ako; Kawasaki, Toshikatsu; Mukohara, Toru
肿瘤
肿瘤免疫
乳腺癌
发表日期：2021
文献求助 收藏